Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

When to Suspect Systemic Mastocytosis?

Sibel Kaplan, MD, Baris Kuskonmaz, MD, özge Ulusoy Soyer, Selin Aytaç, Fatma Gümrük

Blood (2018) 132 (Supplement 1): 5826.

https://doi.org/10.1182/blood-2018-99-119809

Published: 2018

Journal Articles

Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis

Greiner Georg, MD PhD, Michael Gurbisz, MSc, Franz Ratzinger, MD, Nadine Witzeneder, MSc, Ingrid Simonitsch-Klupp, MD, Gerlinde Mitterbauer-Hohendanner, MD, Matthias Mayerhofer, MD, Leonhard Muellauer, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Gregor Hoermann, MD

Blood (2017) 130 (Supplement 1): 2927.

https://doi.org/10.1182/blood.V130.Suppl_1.2927.2927

Published: 2017

Journal Articles

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Blood (2017) 130 (Supplement 1): 1650.

https://doi.org/10.1182/blood.V130.Suppl_1.1650.1650

Published: 2017

Journal Articles

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Blood (2016) 128 (22): 396.

https://doi.org/10.1182/blood.V128.22.396.396

Published: 2016

Journal Articles

Identification of CD44 As a RAS-MEK-Regulated Invasion Receptor That Is Overexpressed in Neoplastic Mast Cells and Triggers Disease Expansion in Advanced Systemic Mastocytosis

Niklas Mueller, MD, Daniel Wicklein, PhD, Gregor Eisenwort, MD PhD, Juliana Schwaab, MD, Mohamad Jawhar, MD, Alexandra Boehm, MD, Harald Herrmann, MD, Gabriele Stefanzl, Gregor Hoermann, Wolfgang R. Sperr, MD, Michel Arock, PharmD,PhD, Andreas Reiter, MD, Udo Schumacher, MD, Peter Valent, MD

Blood (2016) 128 (22): 1955.

https://doi.org/10.1182/blood.V128.22.1955.1955

Published: 2016

Journal Articles

Systemic Mastocytosis Patient Experience from Mast Cell Connect, the First Patient-Reported Registry for Mastocytosis

Philina Lee, PhD, Tracy I. George, MD, Hongliang Shi, MS, Erica K. Evans, PhD, Teghpal Singh, PhD, Anthony L Boral, MD PhD, Vanessa Rangel Miller, MS, MBA, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 4783.

https://doi.org/10.1182/blood.V128.22.4783.4783

Published: 2016

Journal Articles

A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis

Blood (2014) 124 (21): 3188.

https://doi.org/10.1182/blood.V124.21.3188.3188

Published: 2014

Journal Articles

Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature

Ana Carvalhosa, Gandhi Damaj, MD PhD, Danielle Canioni, MD, Laure Cabaret, Nathalie Costédoat-Chalumeau, MD PhD, Pascal Cathebras, MD, Stéphane Durupt, MD, Isabelle Durieu, MD PhD, Emmanuel Gyan, MD PhD, David Launay, MD PhD, Benoit Pilmis, MD, Laurent Frenzel, MD, Olivier Lortholary, MD PhD, Olivier Hermine, MD PhD, Cedric R. Hermans, MD PhD, Marie-Olivia Chandesris, MD

Blood (2014) 124 (21): 2856.

https://doi.org/10.1182/blood.V124.21.2856.2856

Published: 2014

Journal Articles

KIT D816V Mutation Burden Predicts Prognosis and Survival In Patients With Mastocytosis and Correlates With The WHO Type Of The Disease

Gregor Hoermann, M.D., Ph.D., Karoline V. Gleixner, M.D., Graziella E. Dinu, B.Sc., Georg Greiner, Friedrich Wimazal, M.D., Emir Hadzijusufovic, DVM, Gerlinde Mitterbauer, M.D., Christine Mannhalter, Ph.D., Peter Valent, Wolfgang R Sperr, M.D.

Blood (2013) 122 (21): 4052.

https://doi.org/10.1182/blood.V122.21.4052.4052

Published: 2013

Journal Articles

The KIT D816V Allele Burden in Systemic Mastocytosis Is Strongly Associated with Disease Subtype.

Juliana Schwaab, MD, Philipp Erben, MD, Hans-Peter Horny, MD, Martina Teichmann, MD, Georgia Metzgeroth, MD, Thomas Ernst, MD, Karl Sotlar, MD, Martin C Mueller, MD, Alexander Marx, MD, Karin Hartmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Wolf Karsten Hofmann, MD, PhD, Andreas Reiter, MD

Blood (2012) 120 (21): 2859.

https://doi.org/10.1182/blood.V120.21.2859.2859

Published: 2012

Journal Articles

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Gizem Tumer, MD, Tiffany Jow, BS, W. Clark Lambert, MD, PhD

Blood (2011) 118 (21): 5176.

https://doi.org/10.1182/blood.V118.21.5176.5176

Published: 2011

Journal Articles

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Fabiola Traina, MD, PhD, Ania Jankowska, MSC, Hideki Makishima, MD, PhD, Fred H. Hsieh, MD, Yingchun Han, PhD, Christine O'Keefe, PhD, Yuka Sugimoto, MD, PhD, Sanjay R. Mohan, MD, Hadrian Szpurka, PhD, Courtney Prince, Kathryn Guinta, MSC, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Alan E. Lichtin, MD, Anjali S. Advani, MD, Edward Copelan, MD, Ronald Sobecks, MD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Ramon V. Tiu, MD

Blood (2010) 116 (21): 3076.

https://doi.org/10.1182/blood.V116.21.3076.3076

Published: 2010

Journal Articles

Long Term Efficacy and Safety of Cladribine In Adult Systemic mastocytosis: a French Multicenter Study of 44 Patients

Olivier Hermine, MD, PhD, Isabelle Hirsh, Gandhi Damaj, MD, Catherine Granpeix, Stéphane Barète, Felipe Suarez, Olivia Chansderis, David Ghez, Richard Delarue, Fanny Lanternier, Benedicte Deau, MD, Helene Coignard, Sylvie Fraitag, Danielle Canioni, MD, Philippe Casassus, MD, Patrice Dubreuil, Olivier Lortholary

Blood (2010) 116 (21): 1982.

https://doi.org/10.1182/blood.V116.21.1982.1982

Published: 2010

Journal Articles

Activity of Dasatinib Against Novel KIT-N822I Mutation In Familial Cutaneous Mastocytosis

Bartosz Wasag, PhD, Marek Niedoszytko, MD, PhD, Anna Piskorz, PhD, Magdalena Lange, MD, PhD, Joanna Renke, MD, PhD, Ewa Jassem, MD, PhD, Maria Debiec-Rychter, MD, PhD, Janusz Limon, MD, PhD

Blood (2010) 116 (21): 4088.

https://doi.org/10.1182/blood.V116.21.4088.4088

Published: 2010

Journal Articles

UK Single Instituition Experience of Mastocytosis: Guys and St Thomas' NHS Foundation Trust

Nandini Sadasivam, Mufaddal Moonim, Clive Grattan, Jonathan White, Bridget Wilkins, Jon van Der Walt, Nicholas C.P. Cross, Claire N. Harrison, Jennifer Thomson, Deepti Radia

Blood (2010) 116 (21): 5052.

https://doi.org/10.1182/blood.V116.21.5052.5052

Published: 2010

Journal Articles

Establishment of a Highly Sensitive Allele Specific Wild Type Blocker Polymerase Chain Reaction Followed by Pyrosequencing for Detection of the p.D816V Point Mutation.

Udo Siebolts, MD, MSc, Haifa Kathrin Al-Ali, MD, Dietger Niederwieser, MD, Claudia Wickenhauser, MD

Blood (2009) 114 (22): 4975.

https://doi.org/10.1182/blood.V114.22.4975.4975

Published: 2009

Journal Articles

Clinical and Biological Diversity of Clonal Hematological Non-Mast Cell Lineage Neoplasms Associated with Mastocytosis.

Mojdeh Naghashpour, MD, PhD, Ling Zhang, MD, Lynn C. Moscinski, MD

Blood (2009) 114 (22): 4976.

https://doi.org/10.1182/blood.V114.22.4976.4976

Published: 2009

Journal Articles

Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation

Karl M. Hoffmann, Andrea Moser, Peter Lohse, Andreas Winkler, Barbara Binder, Petra Sovinz, Herwig Lackner, Wolfgang Schwinger, Martin Benesch, Christian Urban

Blood (2008) 112 (5): 1655–1657.

https://doi.org/10.1182/blood-2008-03-147785

Published: 2008

Journal Articles

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Finella Brito-Babapulle, Nicholas C.P. Cross

Blood (2007) 110 (11): 3310.

https://doi.org/10.1182/blood.V110.11.3310.3310

Published: 2007

Journal Articles

The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial.

Jason Gotlib, Tracy I. George, Chris Corless, Andrea Linder, Alisa Ruddell, Cem Akin, Daniel J. DeAngelo, Ilana Kepten, Carlo Lanza, Heidrun Heinemann, Ophelia Yin, Neil Gallagher, Tim Graubert

Blood (2007) 110 (11): 3536.

https://doi.org/10.1182/blood.V110.11.3536.3536

Published: 2007

NARROW

When to Suspect Systemic Mastocytosis?

Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Identification of CD44 As a RAS-MEK-Regulated Invasion Receptor That Is Overexpressed in Neoplastic Mast Cells and Triggers Disease Expansion in Advanced Systemic Mastocytosis

Systemic Mastocytosis Patient Experience from Mast Cell Connect, the First Patient-Reported Registry for Mastocytosis

A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis

Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature

KIT D816V Mutation Burden Predicts Prognosis and Survival In Patients With Mastocytosis and Correlates With The WHO Type Of The Disease

The KIT D816V Allele Burden in Systemic Mastocytosis Is Strongly Associated with Disease Subtype.

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Long Term Efficacy and Safety of Cladribine In Adult Systemic mastocytosis: a French Multicenter Study of 44 Patients

Activity of Dasatinib Against Novel KIT-N822I Mutation In Familial Cutaneous Mastocytosis

UK Single Instituition Experience of Mastocytosis: Guys and St Thomas' NHS Foundation Trust

Establishment of a Highly Sensitive Allele Specific Wild Type Blocker Polymerase Chain Reaction Followed by Pyrosequencing for Detection of the p.D816V Point Mutation.

Clinical and Biological Diversity of Clonal Hematological Non-Mast Cell Lineage Neoplasms Associated with Mastocytosis.

Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only